cytarabine and Allergic Bronchopulmonary Mycosis

cytarabine has been researched along with Allergic Bronchopulmonary Mycosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Baggett, MA; Guillory, C; Jones, M; Steele, C; Sullivan, BN	1
Ando, S; Fukayama, M; Gonoi, W; Higo, T; Ishida, M; Kobayashi, T; Kurokawa, M; Nakamura, F; Ohtomo, K; Okuma, H; Ushiku, T; Yamazaki, S	1
Adachi, S; Asami, K; Endo, M; Goto, H; Hanada, R; Hara, J; Hori, T; Horibe, K; Horikoshi, Y; Hosoya, R; Ikuta, K; Kikuta, A; Kobayashi, R; Koike, K; Mugishima, H; Nagatoshi, Y; Nishimura, S; Ohara, A; Ohta, S; Sugita, K; Tsukimoto, I; Tsurusawa, M; Watanabe, A	1

Trials

1 trial(s) available for cytarabine and Allergic Bronchopulmonary Mycosis

Article	Year
[Effectiveness of remission induction with high-dose cytarabine for relapsed or refractory pediatric acute leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:2 Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulse Therapy, Drug; Recurrence; Remission Induction; Treatment Outcome	2010

Article

Year

[Effectiveness of remission induction with high-dose cytarabine for relapsed or refractory pediatric acute leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:2

Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulse Therapy, Drug; Recurrence; Remission Induction; Treatment Outcome

2010

Other Studies

2 other study(ies) available for cytarabine and Allergic Bronchopulmonary Mycosis

Article	Year
Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis. mBio, 2022, 10-26, Volume: 13, Issue:5 Topics: Adrenal Cortex Hormones; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chemokines; Chemokines, CXC; Cytarabine; Daunorubicin; Disease Models, Animal; Humans; Interleukin-17; Interleukin-6; Invasive Pulmonary Aspergillosis; Ligands; Lung; Mice; Pneumonia; Steroids; Vascular Endothelial Growth Factor A	2022
Cerebral embolism through hematogenous dissemination of pulmonary mucormycosis complicating relapsed leukemia. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:10 Topics: Aged; Autopsy; Cytarabine; Fatal Outcome; Female; Humans; Injections, Spinal; Intracranial Embolism; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lung; Methotrexate; Mucormycosis	2015

Article

Year

Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis.

mBio, 2022, 10-26, Volume: 13, Issue:5

Topics: Adrenal Cortex Hormones; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chemokines; Chemokines, CXC; Cytarabine; Daunorubicin; Disease Models, Animal; Humans; Interleukin-17; Interleukin-6; Invasive Pulmonary Aspergillosis; Ligands; Lung; Mice; Pneumonia; Steroids; Vascular Endothelial Growth Factor A

2022

Cerebral embolism through hematogenous dissemination of pulmonary mucormycosis complicating relapsed leukemia.

International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:10

Topics: Aged; Autopsy; Cytarabine; Fatal Outcome; Female; Humans; Injections, Spinal; Intracranial Embolism; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lung; Methotrexate; Mucormycosis

2015